Effectiveness of tranexamic acid on blood loss in patients undergoing elective cesarean section: randomized clinical trial. (отвара нови прозор)

Abdel-Aleem H, Alhusaini TK, Abdel-Aleem MA, Menoufy M, Gülmezoglu AM.

Извор‎: J Matern Fetal Neonatal Med 2013;26(17):1705-9.

Индекс‎: PubMed 23574458

https://www.ncbi.nlm.nih.gov/pubmed/23574458 (отвара нови прозор)

Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients. (отвара нови прозор)

Gayet-Ageron A, Prieto-Merino D, Ker K, Shakur H, Ageron FX, Roberts I; Antifibrinolytic Trials Collaboration

Извор‎: Lancet 2018;391(10116):125-32.

Индекс‎: PubMed 29126600

DOI‎: 10.1016/S0140-6736(17)32455-8

https://www.ncbi.nlm.nih.gov/pubmed/29126600 (отвара нови прозор)

Can intravenous injection of tranexamic acid be used in routine practice with active management of the third stage of labor in vaginal delivery? A randomized controlled study. (отвара нови прозор)

Gungorduk K, Asıcıoğlu O, Yıldırım G, Ark C, Tekirdağ Aİ, Besımoglu B.

Извор‎: Am J Perinatol 2013;30(5):407-13.

Индекс‎: PubMed 23023559

DOI‎: 10.1055/s-0032-1326986

https://www.ncbi.nlm.nih.gov/pubmed/23023559 (отвара нови прозор)

Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study. (отвара нови прозор)

Gungorduk K, Yıldırım G, Asıcıoğlu O, Gungorduk OC, Sudolmus S, Ark C.

Извор‎: Am J Perinatol 2011;28(3):233-40.

Индекс‎: PubMed 20979013

https://www.ncbi.nlm.nih.gov/pubmed/20979013 (отвара нови прозор)

Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. (отвара нови прозор)

Shakur S, Roberts I, Fawole B, Chaudhri R, El-Sheikh M, et al.; WOMAN Trial Collaborators

Извор‎: Lancet 2017;389(10084):2105-16.

Индекс‎: PubMed 28456509

DOI‎: 10.1016/S0140-6736(17)30638-4

https://www.ncbi.nlm.nih.gov/pubmed/28456509 (отвара нови прозор)

Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials. (отвара нови прозор)

Simonazzi G, Bisulli M, Saccone G, Moro E, Marshall A, Berghella V.

Извор‎: Acta Obstet Gynecol Scand 2016;95(1):28-37.

Индекс‎: PubMed 26698831

DOI‎: 10.1111/aogs.12798

https://www.ncbi.nlm.nih.gov/pubmed/26698831 (отвара нови прозор)

Randomized controlled trial of tranexamic acid among parturients at increased risk for postpartum hemorrhage undergoing cesarean delivery. (отвара нови прозор)

Sujata N, Tobin R, Kaur R, Aneja A, Khanna M, Hanjoora VM.

Извор‎: Int J Gynaecol Obstet 2016;133(3):312-5.

Индекс‎: PubMed 26952346

DOI‎: 10.1016/j.ijgo.2015.09.032

https://www.ncbi.nlm.nih.gov/pubmed/26952346 (отвара нови прозор)

Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004. (отвара нови прозор)

Alfirevic Z, Elbourne D, Pavord S, Bolte A, Van Geijn H, Mercier F, Ahonen J, Bremme K, Bødker B, Magnúsdóttir EM, Salvesen K, Prendiville W, Truesdale A, Clemens F, Piercy D, Gyte G.

Извор‎: Obstet Gynecol 2007;110(6):1270-8.

Индекс‎: PubMed 18055720

DOI‎: 10.1097/01.AOG.0000288515.48066.99

https://www.ncbi.nlm.nih.gov/pubmed/18055720 (отвара нови прозор)

The use of recombinant activated FVII in postpartum hemorrhage. (отвара нови прозор)

Franchini M, Franchi M, Bergamini V, Montagnana M, Salvagno GL, Targher G, Lippi G.

Извор‎: Clin Obstet Gynecol 2010;53(1):219-27.

Индекс‎: PubMed 20142658

DOI‎: 10.1097/GRF.0b013e3181cc4378

https://www.ncbi.nlm.nih.gov/pubmed/20142658 (отвара нови прозор)

Recombinant human factor VIIa prevents hysterectomy in severe postpartum hemorrhage: single center study. (отвара нови прозор)

Huber AW, Raio L, Alberio L, Ghezzi F, Surbek DV.

Извор‎: J Perinat Med 2011;40(1):43-9.

Индекс‎: PubMed 22017328

DOI‎: 10.1515/JPM.2011.109

https://www.ncbi.nlm.nih.gov/pubmed/22017328 (отвара нови прозор)

Postpartum hemorrhage: when uterotonics and sutures fail. (отвара нови прозор)

James AH, McLintock C, Lockhart E.

Извор‎: Am J Hematol 2012;87 Suppl 1:S16-22.

Индекс‎: PubMed 22430921

DOI‎: 10.1002/ajh.23156

https://www.ncbi.nlm.nih.gov/pubmed/22430921 (отвара нови прозор)

Recombinant activated factor VII (rFVIIa/NovoSeven®) in the management of severe postpartum haemorrhage: initial report of a multicentre case series in Japan. (отвара нови прозор)

Kobayashi T, Nakabayashi M, Yoshioka A, Maeda M, Ikenoue T.

Извор‎: Int J Hematol 2012;95(1):57-63.

Индекс‎: PubMed 22160834

DOI‎: 10.1007/s12185-011-0974-9

https://www.ncbi.nlm.nih.gov/pubmed/22160834 (отвара нови прозор)

Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial. (отвара нови прозор)

Lavigne-Lissalde G, Aya AG, Mercier FJ, Roger-Christoph S, Chauleur C, Morau E, Ducloy-Bouthors AS, Mignon A, Raucoules M, Bongain A, Boehlen F, de Moerloose P, Bouvet S, Fabbro-Peray P, Gris JC.

Извор‎: J Thromb Haemost 2015;13(4):520-9.

Индекс‎: PubMed 25594352

DOI‎: 10.1111/jth.12844

https://www.ncbi.nlm.nih.gov/pubmed/25594352 (отвара нови прозор)

Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy. (отвара нови прозор)

Lim Y, Loo CC, Chia V, Fun W.

Извор‎: Int J Gynaecol Obstet 2004;87(2):178-9.

Индекс‎: PubMed 15491576

DOI‎: 10.1016/j.ijgo.2004.08.007

https://www.ncbi.nlm.nih.gov/pubmed/15491576 (отвара нови прозор)

Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. (отвара нови прозор)

Moscardó F, Pérez F, de la Rubia J, Balerdi B, Lorenzo JI, Senent ML, Aznar I, Carceller S, Sanz MA.

Извор‎: Br J Haematol 2001;114(1):174-6.

Индекс‎: PubMed 11472364

https://www.ncbi.nlm.nih.gov/pubmed/11472364 (отвара нови прозор)

Successful management by recombinant activated factor VII in a case of disseminated intravascular coagulopathy caused by obstetric hemorrhage. (отвара нови прозор)

Nohira T, Osakabe Y, Suda S, Takahashi C, Tanaka A, Ikeda K, Ikeda T, Okabe K.

Извор‎: J Obstet Gynaecol Res 2008;34(4 Pt 2):623-30.

Индекс‎: PubMed 18840167

https://www.ncbi.nlm.nih.gov/pubmed/18840167 (отвара нови прозор)

Recombinant factor VIIa as last-resort treatment of desperate haemorrhage. (отвара нови прозор)

Palmason R, Vidarsson B, Sigvaldason K, Ingimarsson JP, Gudbjartsson T, Sigurdsson GH, Onundarson PT.

Извор‎: Acta Anaesthesiol Scand 2012;56(5):636-44.

Индекс‎: PubMed 22489992

DOI‎: 10.1111/j.1399-6576.2012.02688.x

https://www.ncbi.nlm.nih.gov/pubmed/22489992 (отвара нови прозор)

Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation. (отвара нови прозор)

Pepas LP, Arif-Adib M, Kadir RA.

Извор‎: Obstet Gynecol 2006;108(3 Pt 2):757-61.

Индекс‎: PubMed 17018493

DOI‎: 10.1097/01.AOG.0000197064.44340.d4

https://www.ncbi.nlm.nih.gov/pubmed/17018493 (отвара нови прозор)

Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry. (отвара нови прозор)

Phillips LE, McLintock C, Pollock W, Gatt S, Popham P, Jankelowitz G, Ogle R, Cameron PA; Australian and New Zealand Haemostasis Registry.

Извор‎: Anesth Analg 2009;109(6):1908-15.

Индекс‎: PubMed 19923520

DOI‎: 10.1213/ANE.0b013e3181c039e6

https://www.ncbi.nlm.nih.gov/pubmed/19923520 (отвара нови прозор)

Recombinant factor VIIa to successfully manage disseminated intravascular coagulation from amniotic fluid embolism. (отвара нови прозор)

Prosper SC, Goudge CS, Lupo VR.

Извор‎: Obstet Gynecol 2007;109(2 Pt2):524-5.

Индекс‎: PubMed 17267882

DOI‎: 10.1097/01.AOG.0000235711.11817.8c

https://www.ncbi.nlm.nih.gov/pubmed/17267882 (отвара нови прозор)

The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage--an observational study. (отвара нови прозор)

Ahmed S, Harrity C, Johnson S, Varadkar S, McMorrow S, Fanning R, Flynn CM, O'Riordan JM, Byrne BM.

Извор‎: Transfus Med 2012;22(5):344-9.

Индекс‎: PubMed 22994449

https://www.ncbi.nlm.nih.gov/pubmed/22994449 (отвара нови прозор)

The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. (отвара нови прозор)

Bell SF, Rayment R, Collins PW, Collis RE.

Извор‎: Int J Obstet Anesth 2010;19(2):218-23.

Индекс‎: PubMed 20194010

DOI‎: 10.1016/j.ijoa.2009.08.004

https://www.ncbi.nlm.nih.gov/pubmed/20194010 (отвара нови прозор)

Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. (отвара нови прозор)

Cortet M, Deneux-Tharaux C, Dupont C, Colin C, Rudigoz RC, Bouvier-Colle MH, Huissoud C.

Извор‎: Br J Anaesth 2012;108(6):984-9.

Индекс‎: PubMed 22490316

DOI‎: 10.1093/bja/aes096

https://www.ncbi.nlm.nih.gov/pubmed/22490316 (отвара нови прозор)

Association between fibrinogen levels and severity of postpartum hemorrhage in singleton vaginal deliveries at a Japanese perinatal center. (отвара нови прозор)

Shibata Y, Shigemi D, Ito M, Terada K, Nakanishi K, Kato M, Igarashi M, Suzuki S.

Извор‎: J Nippon Med Sch 2014;81(2):94-6.

Индекс‎: PubMed 24805095

https://www.ncbi.nlm.nih.gov/pubmed/24805095 (отвара нови прозор)

A systematic review: the use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy. (отвара нови прозор)

Trigg DE, Stergiotou I, Peitsidis P, Kadir RA.

Извор‎: Haemophilia 2012;18(1):25-33.

Индекс‎: PubMed 21624012

DOI‎: 10.1111/j.1365-2516.2011.02573.x

https://www.ncbi.nlm.nih.gov/pubmed/21624012 (отвара нови прозор)

Tisseel for management of traumatic postpartum haemorrhage. (отвара нови прозор)

Dhulkotia JS, Alazzam M, Galimberti A.

Извор‎: Arch Gynecol Obstet 2009;279(3):437-9.

Индекс‎: PubMed 18985368

DOI‎: 10.1007/s00404-008-0824-z

https://www.ncbi.nlm.nih.gov/pubmed/18985368 (отвара нови прозор)

Use of FloSeal haemostatic gel in massive obstetric haemorrhage: a case report. (отвара нови прозор)

Moriarty KT, Premila S, Bulmer PJ.

Извор‎: BJOG 2008;115(6):793-5.

Индекс‎: PubMed 18355369

DOI‎: 10.1111/j.1471-0528.2007.01654.x

https://www.ncbi.nlm.nih.gov/pubmed/18355369 (отвара нови прозор)

Topical application of recombinant activated factor VII during cesarean delivery for placenta previa. (отвара нови прозор)

Schjoldager BTBG, Mikkelsen E, Lykke MR, Præst J, Hvas AM, Heslet L, Secher NJ, Salvig JD, Uldbjerg N

Извор‎: Am J Obstet Gynecol 2017;216(6):608.e1-5.

Индекс‎: PubMed 28219621

DOI‎: 10.1016/j.ajog.2017.02.024

https://www.ncbi.nlm.nih.gov/pubmed/28219621 (отвара нови прозор)

Fibrin sealant for management of complicated obstetric lacerations. (отвара нови прозор)

Whiteside JL, Asif RB, Novello RJ.

Извор‎: Obstet Gynecol 2010;115(2 Pt 2):403-4.

Индекс‎: PubMed 20093858

DOI‎: 10.1097/AOG.0b013e3181bb1e28

https://www.ncbi.nlm.nih.gov/pubmed/20093858 (отвара нови прозор)

Role of thromboelastography versus coagulation screen as a safety predictor in pre-eclampsia/eclampsia patients undergoing lower-segment caesarean section in regional anaesthesia. (отвара нови прозор)

Ahmad A, Kohli M, Malik A, Kohli M, Bogra J, Abbas H, Gupta R, Kushwaha BB.

Извор‎: J Obstet Gynaecol India 2016;66(Suppl 1):340-6.

Индекс‎: PubMed 27651627

https://www.ncbi.nlm.nih.gov/pubmed/27651627 (отвара нови прозор)

Assessment of coagulation in the obstetric population using ROTEM® thromboelastometry. (отвара нови прозор)

Armstrong S, Fernando R, Ashpole K, Simons R, Columb M.

Извор‎: Int J Obstet Anesth 2011;20(4):293-8.

Индекс‎: PubMed 21835606

https://www.ncbi.nlm.nih.gov/pubmed/21835606 (отвара нови прозор)

Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage. (отвара нови прозор)

de Lange NM, Lancé MD, de Groot R, Beckers EA, Henskens YM, Scheepers HC.

Извор‎: Obstet Gynecol Surv 2012;67(7):426-35.

Индекс‎: PubMed 22926249

DOI‎: 10.1097/OGX.0b013e3182605861

https://www.ncbi.nlm.nih.gov/pubmed/22926249 (отвара нови прозор)

Major obstetric haemorrhage: monitoring with thromboelastography, laboratory analyses or both? (отвара нови прозор)

Karlsson O, Jeppsson A, Hellgren M.

Извор‎: Int J Obstet Anesth 2014;23(1):10-7.

Индекс‎: PubMed 24342222

https://www.ncbi.nlm.nih.gov/pubmed/24342222 (отвара нови прозор)

Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. (отвара нови прозор)

Levy JH, Welsby I, Goodnough LT.

Извор‎: Transfusion 2014;54(5):1389-405.

Индекс‎: PubMed 24117955

DOI‎: 10.1111/trf.12431

https://www.ncbi.nlm.nih.gov/pubmed/24117955 (отвара нови прозор)

Coagulopathy and placental abruption: changing management with ROTEM-guided fibrinogen concentrate therapy. (отвара нови прозор)

McNamara H, Mallaiah S, Barclay P, Chevannes C, Bhalla A.

Извор‎: Int J Obstet Anesth 2015;24(2):174-9.

Индекс‎: PubMed 25659517

https://www.ncbi.nlm.nih.gov/pubmed/25659517 (отвара нови прозор)

Haemostatic monitoring during postpartum haemorrhage and implications for management. (отвара нови прозор)

Solomon C, Collis RE, Collins PW.

Извор‎: Br J Anaesth 2012;109(6):851-63.

Индекс‎: PubMed 23075633

DOI‎: 10.1093/bja/aes361

https://www.ncbi.nlm.nih.gov/pubmed/23075633 (отвара нови прозор)